Navigation Links
Improved Bone Grafts With Bioactive cement scaffold

American Dental Association Foundation (ADAF) and the National Institute of Standards and Technology (NIST) have developed a new technology for implants// that will enhance the construction or repair of bones in the face, skull and jaw.

The novel technology will enable a method for making scaffolds for bone tissue. The scaffold is seeded with a patient's own cells and is made from a cement paste consisting of minerals, available in natural bone. The paste is then injected into a bone cavity and then allowed to solidify. The natural polymer beads slowly disintegrate and mix, creating a scaffold that is filled by the recently released bone cells.

"Bone cells are very smart," says Hockin Xu, of the ADAF and principal investigator for the project. "They can tell the difference between materials that are bioactive compared to bioinert polymers. Our material is designed to be similar to mineral in bone so that cells readily attach to the scaffold." properties.

Source: Eureka


'"/>




Page: 1

Related medicine news :

1. Improved height from administration of growth hormones
2. Improved procedure to do laproscopic esophagectomy discovered
3. Improved parent-physician communication to prevent hospitalizations for childhood asthma
4. Testicular Cancer Patients Have Improved Reproductive Outcomes After Treatment
5. Improved cure and activity level seen among patients treated by Vertebroplasty.
6. New Cardiac Angiography Technique For Improved Imaging Of Coronary Veins
7. Minister claims Chinas Epidemic Control System Improved
8. Quality Platelets and Improved Blood Availability No Longer a Pipe Dream
9. Robotic Assisted Knee Replacement Surgery Has Improved Accuracy
10. Latest Version of Echocardiography Provides Improved Pictures of the Heart
11. Reliability of Pacemakers and Defibrillators to be Improved

Post Your Comments:
(Date:11/27/2009)...BC,Nov.27/PRNewswire/-UploadableUSBpedometersmaybe...mbinationofadvancedaccelerometerfunctionalityandau...accuracyofself-reporteddata.It,snowpossibletoaccur...program. ,, CoreHealthTechnologiesisoneofthefir...ealthchallengesareeasytoadministerandparticipatein...
(Date:11/27/2009)...ISCO,Nov.27/PRNewswire-FirstCall/--TheGymboreeCorp...O/COO,willpresentattheNASDAQOMX23rdInvestorProgram...onWednesday,December2,2009,at11:45a.m.GMT. ,, T...resentationovertheInternet,pleaselogontowww.gymbor...o"InvestorandMediaRelations"andthen"ConferenceCall...
(Date:11/27/2009)...HAMIR,Israel,Nov.27/PRNewswire-FirstCall/--ShamirO...dingproviderofinnovativeproductsandtechnologytothe...irectorshaddeclaredadividenddistributioninanaggreg...onbasedontheNovember25,2009representativerateofexc...basedontheNovember25,2009representativerateofexcha...
(Date:11/27/2009)... bring unprecedented medical, economic burdens, st...Day News) -- The number of people with diabetes in...next 25 years, a new study predicts. , That wou...eople with the disease, up from 23.7 million today...ple with diabetes will triple, the study also warn...
(Date:11/27/2009)... Multi-purpose bilingual coloring books d...e by the business community to educate - inform pa...from Safety issues to Dinosuars to ABC,S and a hos...t Louis, MO (PRWEB) November 27, 2009 -- Today&rsq...toys to keep them busy any hour of the day, but on...
Breaking Medicine News(10 mins):Health News:New USB technology adds accountability and convenience to wellness programs 2Health News:Shamir Optical Industry Ltd. Announces Declaration of a Cash Dividend 2Health News:Diabetes Cases Expected to Double in 25 Years 2Health News:Diabetes Cases Expected to Double in 25 Years 3Health News:Really Big Coloring Books Debuts Bi-Lingual Spanish-English Line of Custom and Imprintable Coloring Books 2
...the July 9 issue of Archives of Internal Medicine,...ific antigen (PSA) tests to screen for prostate ca...hom the PSA test is not shown to be beneficial, an...ot recommend routine PSA screening for men younger...
...ished in the July 10, 2007, issue of Neurology, th...logy , People with early Parkinsons disease report...g of hallucinations, sleepiness, and swelling. ...r Kevin Biglan, MD, MPH, with University of Roches...
...n Wednesday lamented opposition from several state...from next year, a report said . "In our co...it and that is why we have a billion population," ...wareness among our children," he was quoted as say...
...s top luxury hotel chains called on the country We...ities or suffer a drop in tourist arrivals . ...rists," said P.R.S. Oberoi, the chairman of the EI...leaning up our cities must happen," he told report...
...rida neuroscientist reports that the cutting-edge ...h Parkinsons disease is compelling on several fron...heir job of easing disease symptoms. Paul R. ...eural Stem Cells for Parkinsons Disease: To Protec...
...n low and middle-income countries can turn out eco...conclusion was reached by A UCSF-led team of rese...ms underway in countries like India, South Africa,... With the recent report from the Global HIV Preven...
Other Medicine News:Health News:Clinicians Ordering Inappropriate Prostate Screenings 2Health News:Early Parkinsons Show Hallucination,sleepiness 2Health News:Stem Cells Research in Parkinsons Disease 2Health News:HIV Prevention Programs on a Massive Scale Turn Out Economical 2
(Date:11/25/2009)...ire/--Reportlinker.comannouncesthatanewmarketresea...raphyEquipment-AGlobalMarketPerspective ,, h...uipment---A-Global-Market-Perspective.html ,, ...lasdevelopingnationsisaprincipalfactorinfluencingg...renessaboutbreastcancerhasallowedwomentocomeforwar...
(Date:11/25/2009)...wire-FirstCall/--NuVasive,Inc.(Nasdaq: NUVA ),amed...imallydisruptivesurgicaltreatmentsforthespine,anno...vember30,2009,at5:30p.m.ET/2:30p.m.PT.Theconferenc...ntfortheCompany,sproductsandwillincludecommentsfro...n.Thedial-innumbersare1-877-407-4018fordomesticcal...
(Date:11/25/2009)...dJOHANNESBURG,November25/PRNewswire/--,iThembaPhar...cedtoday,thattheyhavesignedacollaborativeagreement...is,sworldclasscomputationalchemistryandleaddiscove...iontoprovidemedicinaland,syntheticchemistrysupport...entnetwork.iThembaPharmaceuticalsandPyxisDiscovery...
Breaking Medicine Technology:Reportlinker Adds Mammography Equipment - A Global Market Perspective 2Reportlinker Adds Mammography Equipment - A Global Market Perspective 3Reportlinker Adds Mammography Equipment - A Global Market Perspective 4Reportlinker Adds Mammography Equipment - A Global Market Perspective 5Reportlinker Adds Mammography Equipment - A Global Market Perspective 6Reportlinker Adds Mammography Equipment - A Global Market Perspective 7NuVasive Announces Conference Call and Webcast Regarding Reimbursement 2NuVasive Announces Conference Call and Webcast Regarding Reimbursement 3iThemba Pharmaceuticals (Pty) Ltd and Pyxis Discovery B.V. Announce Collaborative Agreement to Offer a Combined Service Offering 2Congressional Health Care Reform Proposals Would Make Health Care More Expensive Reduce Benefits for Louisianians 61843 1Congressional Health Care Reform Proposals Would Make Health Care More Expensive Reduce Benefits for Louisianians 61843 2AAFPRS Opposes the Proposed Tax on Medical Procedures 61838 1AAFPRS Opposes the Proposed Tax on Medical Procedures 61838 2Genetic analysis helps dissect molecular basis of cardiovascular disease 10845 1Genetic analysis helps dissect molecular basis of cardiovascular disease 10845 2
... YORK, July 28 Polyphenon Pharma, an emerging,res...d that the Food and,Drug Administration (FDA) has ...rug, Polyphenon E(R), for the treatment of chronic...urrently underway at the Mayo Clinic,in Rochester,...cts of an,oral daily dose of Polyphenon E in CLL p...
...NTAIN VIEW, Calif., July 24 Alexza,Pharmaceutical...as initiated,its second Phase 3 clinical trial wit...lation product candidate being developed for the t...ophrenia or bipolar disorder.,Alexza believes the ...ic,(PK) properties resulting from inhaled loxapine...
Other Medicine Technology:Polyphenon Pharma Receives Orphan Drug Designation for Its Botanical Drug, Polyphenon E, for the Treatment of CLL 2Alexza Initiates Second Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine) 2Alexza Initiates Second Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine) 3Alexza Initiates Second Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine) 4Alexza Initiates Second Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine) 5Alexza Initiates Second Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine) 6
Irrigating Cystotome, Formed, 23 g
Peribulbar Needle, 25 g. Atkinson style bevel.
Scleral Blade tip 5700 style, straight
Blade Tip Handle
Medicine Products: